Management of retinopathy of prematurity

Ophthalmology
|August 1, 1985
PubMed

Insights

Cryotherapy effectively treated retinopathy of prematurity (ROP) in premature infants, preventing disease worsening in most treated eyes compared to controls. Further research is needed for statistical significance.

Area of Science:

  • Ophthalmology
  • Neonatology
  • Pediatric Medicine

Background:

  • Retinopathy of prematurity (ROP) is a leading cause of childhood blindness.
  • Premature infants, especially those under 1000 grams, are at high risk for severe ROP.
  • Plus disease indicates aggressive ROP requiring prompt intervention.

Purpose of the Study:

  • To evaluate the efficacy of cryotherapy in treating stage 3 retinopathy of prematurity with plus disease.
  • To compare outcomes of cryotherapy versus observation in affected eyes.

Main Methods:

  • A randomized controlled trial involving 17 premature infants with symmetrical stage 3 ROP and plus disease.
  • One eye per patient was randomized to cryotherapy, the other served as a control.
  • Cryotherapy was administered at an average age of three months.

Main Results:

  • 71% of cryotherapy-treated eyes showed ROP resolution.
  • 59% of untreated control eyes worsened significantly.
  • Limited cases (5/17) showed treated eye improvement and untreated eye progression, insufficient for statistical significance.

Conclusions:

  • Cryotherapy demonstrates a positive trend in resolving ROP and preventing progression in premature infants.
  • While promising, larger studies are needed to establish statistical significance for cryotherapy's benefits in ROP treatment.
  • Surgical intervention (scleral buckling) was required for advanced ROP with retinal detachment in some cases.